Bladder Leaks, GSM, and Postmenopausal Bleeding: Three Women’s Health Topics Worth Talking About
There are health topics women manage quietly for years, sometimes decades, before realizing that real, evidence-backed solutions exist. Bladder leaks. Vaginal dryness. Bleeding on hormone therapy. These aren’t fringe complaints. They’re among the most common experiences women face in midlife and beyond, and they deserve a frank, informed conversation.
This article covers all three:
- what’s actually happening in your body,
- why it matters, and
- what can genuinely help.
Part One: Bladder Leaks and Urinary Incontinence
You Are Not Alone, and You Are Not Out of Options
If you’ve ever crossed your legs when you sneeze, rushed to the bathroom the moment you hear running water, or quietly started wearing a pad “just in case,” you’re in significant company. In Canada, nearly 29% of women report some degree of urinary incontinence (UI). Yet only a fraction ever bring it up with a healthcare provider, largely because many women believe it’s a normal part of aging or having had children.
It isn’t. Urinary incontinence is not a disease. It’s a symptom. Symptoms have causes. Causes have solutions.
What’s Actually Happening
Your bladder is a muscle. It fills, signals the brain when it’s ready, and ideally empties when you decide the timing is right. Incontinence happens when that system breaks down, when pressure in the abdomen from a cough, sneeze, jump, or sudden urge exceeds the bladder’s ability to hold on.
There are a few distinct types worth knowing:
Stress incontinence involves leakage triggered by physical exertion, coughing, sneezing, or laughing. It’s the most common type.
Urgency incontinence is characterized by a sudden, strong urge to urinate that’s difficult to suppress, sometimes resulting in leakage before reaching the bathroom.
Mixed incontinence is a combination of both. Each type has different underlying drivers and responds to different treatments, which is why understanding which type you have matters.
Who Is at Risk?
Several factors increase a woman’s likelihood of developing UI:
Vaginal childbirth increases the risk of stress incontinence, and that risk rises with each delivery. Perimenopause and menopause bring declining estrogen, which affects the tissues of the bladder, urethra, and pelvic floor. Obesity increases intra-abdominal pressure. Chronic constipation places mechanical stress on pelvic support structures, and one meta-analysis found it was associated with more than double the risk of UI. Hysterectomy, smoking, and high-impact exercise are also recognized contributors.
The takeaway: these are understandable, addressable factors, not inevitable fates.
What Actually Helps
Only 25% of women with urinary incontinence ever seek or receive treatment, despite the fact that effective, non-surgical options exist at every stage. Here’s what the evidence supports.
Pelvic floor muscle training (PFMT) is the recommended first-line treatment for all types of urinary incontinence in women, according to Canadian and international guidelines. Most people know these as Kegel exercises, but the nuance matters: professionally supervised PFMT is significantly more effective than self-directed exercise at home. A Cochrane review found women who completed PFMT were 8 times more likely to report cure than those in control groups, with improvements of 50 to 80% in leakage episodes regularly reported in well-supervised programs. Working with a pelvic floor physiotherapist makes a real difference.
Bladder training is a first-line behavioural approach for urgency and mixed incontinence, carrying a Grade A evidence recommendation from both the Canadian Urological Association and the European Association of Urology. It involves gradually extending the time between bathroom visits using a scheduled plan, alongside techniques to suppress urgency. It typically takes about six weeks and works best with practitioner support.
Targeted lifestyle changes backed by evidence include reducing caffeine intake, managing fluid timing, treating constipation, quitting smoking, and achieving a healthy weight. Weight loss in particular consistently reduces UI severity in overweight women.
Vaginal estrogen has strong evidence for improving urgency incontinence, stress incontinence, urinary frequency, and recurrent UTIs in perimenopausal and menopausal women. It’s local, not systemic, estrogen that helps here, and it’s supported by the Canadian Urological Association, the European Association of Urology, and The Menopause Society.
Pessaries and intravaginal supports offer a non-hormonal, non-surgical option for women who want to manage leakage during activity. A continence pessary is a silicone device fitted inside the vagina to support the bladder neck. Continuation rates are high, over 75% at two or more years.
When conservative approaches aren’t enough, minimally invasive options like urethral bulking agents and mid-urethral sling surgery exist with excellent long-term outcomes for well-selected patients. These are specialist conversations, but knowing they’re available makes the early work feel like what it is: a solid foundation.
The most important first step is simply starting the conversation. If you’ve been quietly managing bladder symptoms, whether leaking when you laugh, rushing to the bathroom, or waking at night to urinate, bring it up at your next visit. There is no shame in asking, and there is often a great deal of relief in what comes next.
Part Two: GSM (Genitourinary Syndrome of Menopause)
What It Is, Why It Happens, and Why It’s So Rarely Talked About
If you’ve never heard of GSM, you’re not alone. But chances are, you or someone you know has experienced it.
GSM stands for Genitourinary Syndrome of Menopause. In plain terms, it refers to a group of changes that can affect the vaginal, urinary, and sexual systems after menopause, driven by declining estrogen levels. It may sound clinical, but in real life it shows up in ways many women recognize immediately.
As estrogen drops during and after menopause, the tissues of the vagina, vulva, urethra, and bladder can become thinner, drier, and more sensitive. This can show up as vaginal dryness, burning, or itching; discomfort or pain during intercourse; urinary urgency or irritation; changes in pubic hair; and in some cases, pelvic organ prolapse.
GSM doesn’t look the same for everyone. Some women notice mainly sexual changes, others mostly urinary symptoms, and some experience both.
The UTI Connection
One aspect of GSM that often surprises women: it significantly increases the risk of recurrent urinary tract infections. Lower estrogen levels affect the health of the tissues in the urinary and vaginal areas, making them more vulnerable to infection. Dryness, irritation, and shifts in the natural vaginal environment all contribute.
If you’ve found yourself thinking, “Why am I suddenly getting more UTIs?”, GSM may be part of the picture.
How Common Is It?
Very. Studies suggest up to 85% of women will experience GSM within 20 years after menopause. This is not a rare condition affecting a small subset of women. It’s one of the most common experiences of the postmenopausal years, and yet it remains significantly underdiagnosed and undertreated, largely because it falls into the category of things women don’t casually discuss.
What Can Help
The good news is that options exist, ranging from simple to more targeted.
Non-hormonal first-line options include vaginal lubricants (used during sexual activity) and vaginal moisturizers (used regularly throughout the week). These can meaningfully improve comfort and day-to-day symptoms for many women.
For women with more persistent or bothersome symptoms, low-dose vaginal estrogen is a prescription option with strong evidence behind it. Like the vaginal estrogen used for urinary incontinence, this is local rather than systemic treatment, making it appropriate for a wide range of women, including many who might hesitate around systemic hormone therapy.
GSM is not something you simply have to live with. It’s a recognized medical condition with real solutions, and addressing it can meaningfully improve comfort, sexual health, urinary health, and quality of life.
Part Three: Postmenopausal Bleeding While on HRT
What’s Normal, What to Watch, and When to Call Your Provider
Postmenopausal bleeding has traditionally been considered a warning sign that warrants prompt medical attention. That remains true. But for women using hormone replacement therapy (HRT), it’s also important to know that bleeding can be a common and expected part of the early adjustment period.
What to Expect When Starting HRT
When you start HRT, your body is adjusting to new hormone levels after a period of estrogen and progesterone decline. During this adjustment window, light bleeding or spotting within the first three to six months is not unusual. It’s often temporary and tends to settle as the uterine lining stabilizes.
It’s also worth knowing that any change to your HRT, including adjusting the dose or switching from a pill to a patch, can effectively restart this adjustment period. After a change, it’s reasonable to allow up to another three months of monitoring as your body adapts to the new regimen.
Common Reasons for Bleeding on HRT
In many cases, bleeding while on HRT is not a sign of something serious. Common causes include adjustment to new hormone levels, missed or inconsistent doses, a recent change in HRT type, dose, or method, an imbalance between estrogen and progesterone, vaginal dryness or tissue thinning, and benign growths such as polyps.
When to Check In With Your Provider
Even though bleeding can be normal in the context of HRT, certain patterns warrant follow-up:
Bleeding that lasts longer than six months after starting HRT should be investigated. So should bleeding that continues more than three months after a dose or formula change, new bleeding after a long symptom-free period, or heavy, prolonged, or painful bleeding.
Your provider may recommend further assessment to confirm that everything is safe and appropriate. The goal isn’t to alarm, but to ensure that the adjustment you’re experiencing is exactly that, and not something that needs a different kind of attention.
The Reassurance Worth Having
Bleeding after menopause can feel alarming. For women on HRT, it is often a normal and manageable part of the process, particularly early on or after changes to treatment. Monitoring your symptoms and maintaining open communication with your healthcare provider are the two most important things you can do.
If you have questions about your HRT or any new symptoms, don’t hesitate to reach out. That’s precisely what we’re here for.
Putting It All Together
Bladder leaks. Vaginal dryness. Bleeding on hormone therapy. Three separate topics, but a common thread running through all of them: these are experiences that millions of women navigate quietly, often for years, without knowing that evidence-based support exists.
Age is not a reason to skip treatment. These are not just things to manage with pads, lubricants, or worry. They are addressable, and addressing them can make a meaningful difference to daily comfort, intimacy, sleep, and quality of life.
If any of these topics resonated with you, consider it an invitation to bring them up at your next visit. Informed women make empowered decisions. That’s what we’re here to support.